FINWIRES · TerminalLIVE
FINWIRES

CStone Pharmaceuticals Plans Share Buyback

By

CStone Pharmaceuticals (HKG:2616) intends to buy back up to nearly 136.5 million shares from the open market from time to time under a mandate approved June 25, 2025, according to a Wednesday Hong Kong bourse filing.

The repurchase plan is expected to be implemented following the American Society of Clinical Oncology (ASCO) Annual Meeting.

Related Articles

Asia

China Electronics Optics Renews Financial Services Contract with Affiliate

China Electronics Optics Valley Union (HKG:0798) renewed an agreement to continue obtaining deposit, loan, and other financial services from China Electronics Financial, according to a Wednesday Hong Kong bourse filing.The renewal, which comes as the current agreement between the parties will expire June 29, is subject to shareholder approval.China Electronics Financial is a unit of China Electronics Corporation, which is a substantial shareholder of China Electronics Optics Valley Union.

$HKG:0798
Asia

Market Chatter: Vietnam Boosts Refined Petroleum Products Purchase in March-April

Vietnam's refined fuel imports rose nearly 17% in the March to April, Reuters reported Wednesday, citing the country's customs data.In terms of value, refined fuel imports were up 144% compared with a year earlier, the report said.The adjustment helped ease immediate supply pressures due to the Iran war, though it added strain to the country's trade balance, the report said.Inflation also accelerated to 5.46% in April, exceeding the government's 4.5% target.Vietnam increased imports from Malaysia and South Korea to make up for the declining fuel supplies from Singapore and China, the news agency reported, citing the data.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^HNX$^HOSE
Asia

Central China Real Estate's Contracted Sales Climb Slightly in April

Central China Real Estate's (HKG:0832) contracted sales jumped 0.8% year over year to 604 million yuan in April, while gross floor area (GFA) slipped 11% to 86,360 square meters, according to a Wednesday Hong Kong bourse filing.The property firm's average selling price for the three months stood at 6,994 yuan per square meter, up 13% from a year prior.For the first four months of 2026, contracted sales and GFA fell 18% and 25%, respectively, to 2.22 billion yuan and 338,285 square meters, with average selling price rising 8.9% to 6,563 yuan per square meter.

$HKG:0832